iSERA Lifesciences Share Swap Acquisition of iSERA Biological

• iSERA Lifesciences seeks shareholder approval via postal ballot for seven resolutions including a ₹78 crore acquisition of iSERA Biological through a 1:1 share swap.
• The company proposes to increase authorized share capital from ₹11 crore to ₹25 crore and adopt new MOA/AOA compliant with Companies Act 2013.
• Resolutions include enhancing investment limits to ₹1,000 crore and issuing 1.62 crore equity shares at ₹48.20 each to iSERA Biological shareholders.